Search Results - "RATNER, Yael"
-
1
Validity of an Abbreviated Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) for Schizophrenia, Schizoaffective, and Mood Disorder Patients
Published in Quality of life research (01-09-2005)“…We sought to identify a core subset of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) items that maintains the validity and psychometric…”
Get full text
Journal Article -
2
Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions
Published in Scientific reports (16-05-2016)“…Most of the existing data on real-life management of bipolar disorder are from studies conducted in western countries (mostly United States and Europe). This…”
Get full text
Journal Article -
3
Determinants of Changes in Perceived Quality of Life in the Course of Schizophrenia
Published in Quality of life research (01-04-2006)“…This study aimed to identify factors that influence changes in satisfaction with quality of life (QOL) of schizophrenia patients. Baseline and follow up data…”
Get full text
Journal Article -
4
State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients
Published in European neuropsychopharmacology (01-03-2007)“…Abstract Objective: In previous studies we have demonstrated high serum molar ratios of cortisol to dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS)…”
Get full text
Journal Article -
5
The characterization of social anhedonia and its correlates in schizophrenia and schizoaffective patients
Published in Psychiatry research (01-12-2018)“…•The ACIPS is a 17-item self-report measure of social hedonic capacity.•We administered the ACIPS to 125 schizophrenia and schizoaffective patients.•The…”
Get full text
Journal Article -
6
Predicting Predischarge Anhedonia Among Inpatients With Schizophrenia and Schizoaffective Disorders: A Large-scale Analysis
Published in The journal of nervous and mental disease (01-01-2019)“…ABSTRACTThis study sought to evaluate predischarge anhedonia level and its predictors in 125 inpatients with schizophrenia and schizoaffective disorders…”
Get full text
Journal Article -
7
Patients' satisfaction with hospital health care: Identifying indicators for people with severe mental disorder
Published in Psychiatry research (01-12-2018)“…•Inpatients with severe mental disorder are quite heterogenic regarding their perception of health services.•Personality factors are more important than…”
Get full text
Journal Article -
8
T210. PSYCHOSOCIAL CORRELATES OF INTERPERSONAL PLEASURE IN SCHIZOPHRENIA-SPECTRUM PATIENTS
Published in Schizophrenia bulletin (01-04-2018)“…Abstract Background Although many people with schizophrenia-spectrum disorders report high levels of social anhedonia, it is not clear what differentiates…”
Get full text
Journal Article -
9
L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study
Published in The journal of clinical psychiatry (01-01-2011)“…L-theanine is a unique amino acid present almost exclusively in the tea plant. It possesses neuroprotective, mood-enhancing, and relaxation properties. This is…”
Get full text
Journal Article -
10
Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis
Published in Biological psychiatry (1969) (01-08-2004)“…The genes G72/G30 were recently implicated in schizophrenia in both Canadian and Russian populations. We hypothesized that 1) polymorphic changes in this gene…”
Get full text
Journal Article -
11
Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients
Published in Clinical neuropharmacology (01-07-2011)“…L-Theanine (γ-glutamylethylamide) augmentation to antipsychotic therapy ameliorates positive, activation, and anxiety symptoms in schizophrenia and…”
Get full text
Journal Article -
12
Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia : A randomized, double-blind, placebo-controlled, crossover trial
Published in Journal of clinical psychopharmacology (01-10-2006)“…Dehydroepiandrosterone (DHEA) augmentation has been reported, in a preliminary fashion, to be useful in the management of schizophrenia symptoms and side…”
Get full text
Journal Article -
13
Improvement of aggressive behavior and quality of life impairment following S -Adenosyl-Methionine (SAM-e) augmentation in schizophrenia
Published in European neuropsychopharmacology (01-01-2009)“…Abstract S -Adenosyl-Methionine (SAM-e), functions as a primary methyl group donor for several metabolic compounds. Since SAM-e is involved in several…”
Get full text
Journal Article -
14
Coping patterns as a valid presentation of the diversity of coping responses in schizophrenia patients
Published in Psychiatry research (15-11-2006)“…This study aimed to identify coping patterns used by schizophrenia inpatients in comparison with those used by healthy individuals, and to explore their…”
Get full text
Journal Article -
15
Predictors of Quality of Life in major psychoses: A naturalistic follow-up study
Published in The journal of clinical psychiatry (01-03-2003)“…Improved quality of life (QOL) of patients suffering from major psychoses has become an important treatment goal. We sought to determine predictors of…”
Get full text
Journal Article -
16
Positive family history is associated with persistent elevated emotional distress in schizophrenia: Evidence from a 16-month follow-up study
Published in Psychiatry research (03-12-2007)“…Abstract There is some evidence that emotional reactivity to daily life stress is related to a genetic or familial liability to develop schizophrenia. However,…”
Get full text
Journal Article -
17
Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: A naturalistic comparative study
Published in Journal of clinical psychopharmacology (01-12-2004)“…Findings in previous studies investigating the beneficial effect of risperidone and olanzapine versus typical antipsychotics on quality of life (QOL) are…”
Get full text
Journal Article -
18
Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: A 12-month, open-label, flexible-dose, naturalistic observational trial
Published in Progress in neuro-psychopharmacology & biological psychiatry (01-10-2007)“…This is a first report from a long-term study aimed to evaluate efficacy, safety, tolerability, cognitive functioning, and quality of life outcomes during…”
Get full text
Journal Article -
19
Cortisol Dehydroepiandrosterone Ratio and Responses to Antipsychotic Treatment in Schizophrenia
Published in Neuropsychopharmacology (New York, N.Y.) (01-10-2005)“…Dehydroepiandrosterone (DHEA) or their sulfate conjugate (DHEAS) (together abbreviated DHEA(S)) exert multiple effects in the central nervous system, and may…”
Get full text
Journal Article -
20
The Long-Term Changes in Coping Strategies in Schizophrenia: Temporal Coping Types
Published in The journal of nervous and mental disease (01-04-2006)“…This prospective study aimed to define the long-term changes in coping strategies used by schizophrenia patients and their relation to clinical and…”
Get full text
Journal Article